dipyridamole has been researched along with African Sleeping Sickness in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bland, ND | 1 |
| Wang, C | 1 |
| Tallman, C | 1 |
| Gustafson, AE | 1 |
| Wang, Z | 1 |
| Ashton, TD | 1 |
| Ochiana, SO | 1 |
| McAllister, G | 1 |
| Cotter, K | 1 |
| Fang, AP | 1 |
| Gechijian, L | 1 |
| Garceau, N | 1 |
| Gangurde, R | 1 |
| Ortenberg, R | 1 |
| Ondrechen, MJ | 1 |
| Campbell, RK | 1 |
| Pollastri, MP | 1 |
1 other study available for dipyridamole and African Sleeping Sickness
| Article | Year |
|---|---|
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Benzamides; Catalytic Domain; Humans; Models, Molecular; Molecu | 2011 |